We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Actavis to Acquire U.S. Generic Firm Amide for $500 Million
Actavis to Acquire U.S. Generic Firm Amide for $500 Million
May 20, 2005
International generic drug company Actavis Group is expanding into the U.S. market through the purchase of privately held U.S. generic firm Amide Pharmaceutical.